The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $130.99

Today's change+1.19 +0.92%
Updated May 27 4:04 PM EDT. Delayed by at least 15 minutes.
 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $130.99

Today's change+1.19 +0.92%
Updated May 27 4:04 PM EDT. Delayed by at least 15 minutes.

Thermo Fisher Scientific Inc up (U.S.)$1.19

Thermo Fisher Scientific Inc closed up Wednesday by (U.S.)$1.19 or 0.92% to (U.S.)$130.99. Shares have lost 0.78% over the last five days, but have gained 4.55% over the last year to date. This security has outperformed the S&P 500 by 2.45% during the last year.

Key company metrics

  • Open(U.S.) $130.51
  • Previous close(U.S.) $129.80
  • High(U.S.) $131.14
  • Low(U.S.) $129.93
  • Bid / Ask(U.S.) $127.77 / (U.S.) $136.00
  • YTD % change+4.55%
  • Volume1,356,333
  • Average volume (10-day)1,546,296
  • Average volume (1-month)1,760,268
  • Average volume (3-month)1,641,263
  • 52-week range(U.S.) $107.33 to (U.S.) $139.03
  • Beta0.92
  • Trailing P/E30.40×
  • P/E 1 year forward17.67×
  • Forward PEG1.90×
  • Indicated annual dividend(U.S.) $0.60
  • Dividend yield0.46%
  • Trailing EPS(U.S.) $4.31
Updated May 27 4:04 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+10.28%

Based on its net profit margin of 10.28%, Thermo Fisher Scientific Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.40%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 28, 201503/28/2015Dec 31, 201412/31/2014Sep 27, 201409/27/2014Jun 28, 201406/28/2014
Revenue3,9194,4934,1714,322
Total other revenue--------
Total revenue3,9194,4934,1714,322
Gross profit1,8232,0921,9341,847
Total cost of revenue2,0962,4012,2382,475
Total operating expense3,4323,8543,5313,974
Selling / general / administrative1,1371,2241,2081,239
Research & development166183175184
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)3246-9076
Other operating expenses, total--------
Operating income487639640348
Interest income (expense), net non-operating-108-116-117-129
Gain (loss) on sale of assets--------
Other--------
Income before tax382537539237
Income after tax385604470279
Income tax, total-3-6769-42
Net income385601472279
Total adjustments to net income--------
Net income before extra. items385604470279
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items385604470279
Inc. avail. to common incl. extra. items385601472279
Diluted net income385601472279
Dilution adjustment--0----
Diluted weighted average shares401404404403
Diluted EPS excluding extraordinary itemsvalue per share0.961.491.160.69
Dividends per sharevalue per share0.150.150.150.15
Diluted normalized EPSvalue per share1.011.570.970.81